You are here

Article info

Article menu
Download PDFPDF
Colorectal
Research
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres

Authors

  1. Correspondence to Mark A Samaan, Guy's & St Thomas' NHS Foundation Trust, Department of Gastroenterology, First Floor College House, North Wing, St Thomas' Hospital, Westminster Bridge Road, London SE1 7EH, UK; markasamaan{at}gmail.com
View Full Text

Citation

Samaan MA, Pavlidis P, Johnston E, et al
Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres
Frontline Gastroenterology 2017;8:196-202.

Publication history

  • Received May 17, 2016
  • Revised July 1, 2016
  • Accepted July 18, 2016
  • First published August 10, 2016.
Online issue publication 
June 05, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/